BioMarin (BMRN) legal chief has 1,273 shares withheld for taxes

Rhea-AI Filing Summary

BioMarin Pharmaceutical executive George Eric Davis, EVP and Chief Legal Officer, reported a routine share disposition related to taxes. On this date, 1,273 shares of common stock were withheld to cover tax obligations at $56.05 per share. After this tax-withholding transaction, he directly holds 78,560 shares of BioMarin common stock, indicating he retains a substantial equity position and that the filing reflects a compensation-related event rather than an open-market sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis George Eric

(Last) (First) (Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

770 LINDARO STREET

(Street)

SAN RAFAEL CALIFORNIA 94901

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		F		1,273	D	$56.05	78,560	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Tae Sang Yoo, Attorney-in-Fact	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did BioMarin (BMRN) report for George Eric Davis?

BioMarin reported that EVP and Chief Legal Officer George Eric Davis had 1,273 common shares withheld to satisfy tax obligations. This tax-withholding disposition is a routine administrative event tied to equity compensation, not an open-market purchase or sale of stock.

How many BioMarin (BMRN) shares were involved in the latest tax-withholding event?

The filing shows 1,273 shares of BioMarin common stock were withheld to cover taxes. These shares were valued at $56.05 each, reflecting the price used for the tax calculation associated with Davis’s equity compensation.

Does the Davis Form 4 for BioMarin (BMRN) indicate an open-market sale?

No, the transaction is coded as a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy tax liabilities arising from equity compensation, so it does not reflect an active decision to sell shares on the open market.

How many BioMarin (BMRN) shares does George Eric Davis hold after this transaction?

Following the tax-withholding disposition, Davis directly holds 78,560 shares of BioMarin common stock. This remaining stake indicates he continues to maintain a sizable ownership position in the company after the routine compensation-related share withholding.

What does a tax-withholding disposition mean for BioMarin (BMRN) insiders?

A tax-withholding disposition means the company withholds shares to pay taxes due on equity compensation. For BioMarin insiders like Davis, it is a standard mechanism to satisfy tax liabilities without executing an open-market sale of their stock.